MolPort is pleased to announce that it has joined the Pistoia Alliance, a global, not-for-profit alliance of Life Sciences organizations that work together to lower barriers to innovation in R&D.
The Pistoia Alliance is a global, not-for-profit members' organization made up of life science companies, technology and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 150 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using The Pistoia Alliance's proven framework for open innovation. For further information visit www.pistoiaalliance.org.
MolPort is already a key player in this R&D community, providing widely used, full-cycle, small molecule sourcing and procurement services: and it has already embarked on a pre-competitive project to crowd-source solubility data on commercially available screening compounds.
MolPort's compound sourcing service is based on high quality, up-to-date, reliable databases which increase researchers' efficiency and help speed up drug discovery R&D. Fast intelligent searching and filtering coupled with MolPort's expertise in sample logistics management and execution free up researchers time to focus on science and not administration. MolPort is looking forward to working collaboratively with other Pistoia Alliance members to share its unparalleled sourcing and logistics expertise in pre-competitive initiatives that remove barriers to successful R&D.
For details please contact us on email@example.com.